Table 1.
Primer sequences used for real-time PCR.
Table 2.
Demographics and results of ocular surface parameters of patients.
Fig 1.
The levels of IL-17A, IL-6 and IL-23 in tears of control group and DED patients in SS and non-SS group.
Results represent the mean ± SD. The P values were determined with ANOVA test. SS, Sjögren’s syndrome; non-SS, non- Sjögren’s syndrome.*, P < .05; **, P < .01.
Fig 2.
The mRNA expressions of IL-17A, IL-6 and IL-23 in conjunctival epithelial cells of control group and DED patients in SS and non-SS group.
Results represent the mean ± SD. The P values were determined with ANOVA test. SS, Sjögren’s syndrome; non-SS, non- Sjögren’s syndrome. *, P< .05; **, P < .01.
Fig 3.
Correlation between levels of IL-17A and IL-6 in tears and ocular surface parameters including OSDI score (A, E), Schirmer I Test (B, F), BUT (C, G), and CFS (D, H).
The R and P values were determined with Spearman correlation coefficient. IL, interleukin; OSDI, ocular surface disease index; BUT, break up time; CFS, corneal fluorescent staining.
Fig 4.
Correlation between conjunctival mRNA expressions of IL-17A and IL-6 and ocular surface parameters including OSDI score (A, E), Schirmer I Test (B, F), BUT (C, G), and CFS (D, H).
The R and P values were determined with Spearman correlation coefficient.IL, interleukin; OSDI, ocular surface disease index; BUT, break up time; CFS, corneal fluorescent staining.